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A number of cyclins have been described, most of which act together with their catalytic
partners, the cyclin-dependent kinases (Cdks), to regulate events in the eukaryotic cell
cycle. Cyclin C was originally identified by a genetic screen for human and Drosophila
cDNAs that complement a triple knock-out of the CLN genes in Saccharomyces cerevisiae.
Unlike other cyclins identified in this complementation screen, there has been no evi-
dence that cyclin C has a cell-cycle role in the cognate organism. Here we report that
cyclin C is a nuclear protein present in a multiprotein complex. It interacts both in vitro
and in vivo with Cdk8, a novel protein-kinase of the Cdk family, structurally related to
the yeast SrblO kinase. We also show that Cdk8 can interact in vivo with the large subunit
of RNA polymerase II and that a kinase activity that phosphorylates the RNA polymer-
ase II large subunit is present in Cdk8 immunoprecipitates. Based on these observations
and sequence similarity to the kinase/cyclin pair SrblO/Srbll in S. cerevisiae, we suggest
that cyclin C and Cdk8 control RNA polymerase II function.
INTRODUCTION
First named after its cyclical accumulation during
early embryonic cell cycles, cyclin B is now the proto-
type of a growing family of structurally related cyclin
molecules that are involved in specific association
with and activation of serine-threonine protein ki-
nases termed Cdks (for cyclin-dependent kinases) (for
review see Morgan, 1995). The function of these cy-
clin/Cdk pairs has been particularly well established
in the control of the eukaryotic cell cycle where several
of these activities trigger the major transitions of the
cell cycle via the phophorylation of a series of cellular
targets (reviewed in King et al., 1994; Nurse, 1994;
Sherr, 1994; Nigg, 1995).
Cyclin/Cdk pairs do not only function in the control
of the cell cycle; a growing number of studies impli-
11 Corresponding author.
cate Cdks in other cellular processes. In yeast, the
Pho8O-Pho85 cyclin-Cdk complex is involved in a
pathway that senses inorganic phosphate in the cell
(Hirst et al., 1994; Kaffman et al., 1994). In high phos-
phate conditions, the Pho8O-Pho85 kinase phosphory-
lates Pho4, a transcriptional activator of the PH05
gene. This phophorylation correlates with negative
regulation of the PH05 gene and is itself modulated
by an additional factor, Pho8l, which shows structural
similarities with the mammalian Cdk inhibitor pl6ink4
(Schneider et al., 1994).
Another cyclin-kinase pair has been recently identi-
fied as a component of the basal transcription factor
TFIIH. Cdk7 (previously called Mol5) and cyclin H,
two subunits of a kinase complex previously identi-
fied as CAK (Cdk-activating kinase) (Fesquet et al.,
1993; Poon et al., 1993; Solomon et al., 1993; Fisher and
Morgan, 1994; Makela et al., 1994; Tassan et al., 1994)
were shown to co-purify with other TFIIH subunits.
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They are associated with the kinase activity of TFIIH
that phosphorylates the C-terminal domain (CTD) of
the RNA polymerase (Pol) IL large subunit (Feaver et
al., 1994; Roy et al., 1994; Serizawa et al., 1995;
Shiekhattar et al., 1995).
More recently, three different genetic approaches
have led to the characterization of a new cyclin-kinase
pair involved in transcriptional control in yeast. SRB1O
and SRB11 (Liao et al., 1995) are part of a group of
genes identified as suppressors of partial truncations
of the CTD that lead to a cold-sensitive phenotype
(Koleske et al., 1992; Thompson et al., 1993). Alleles of
these genes were isolated in two other searches for
genes involved in transcriptional repression: SRB1O
(alias AREl) as a repressor of a-specific genes in a-cells
(Wahi and Johnson, 1995) and SRB1O and SRB11 (alias
SSN3 and SSN8) as repressors of genes in response to
glucose (Kuchin et al., 1995). SrblO and Srbll proteins
are part of a large complex called holoenzyme, con-
sisting of the RNA Pol II core enzyme, a subset of
general transcription factors and the other members of
the SRB group of proteins (Hengartner et al., 1995; Liao
et al., 1995; for review see Koleske and Young, 1995).
Genetic and biochemical results indicate that SrblO
and Srbll form a kinase-cyclin pair whose function is
essential for proper transcriptional control in vivo and
for CTD phosphorylation in vitro (Liao et al., 1995).
The SRB1O gene encodes a Cdk and is identical to the
UME5 gene that was previously implicated in tran-
scriptional control of meiosis-specific genes (Surosky
et al., 1994). SRB11 encodes a cyclin-like protein that is
most similar to human and Drosophila cyclin Cs.
Cyclin C was initially suspected to function as a
regulator of the Gl/S transition in metazoa, because
the human and Drosophila cDNAs were originally iso-
lated in screens for clones capable of rescuing yeast
deficient in the Gl cyclins (Lahue et al., 1991; Leopold
and O'Farrell, 1991; Lew et al., 1991). Three metazoan
cyclins, cyclin C, D, and E were found to complement
a defect in the yeast CLN genes. Numerous laborato-
ries have now demonstrated that cyclin E and cyclin D
with their kinase partners indeed function in the tran-
sition to S phase (for review see Sherr, 1994). In con-
trast, the function of cyclin C has not yet been eluci-
dated.
Here we report that cyclin C is a nuclear protein that
participates in a large multiprotein complex. It inter-
acts in vivo with DmCdk8, a new protein kinase of the
Cdk family (Tassan et al., 1995), structurally related to
the yeast SrblO kinase (Liao et al., 1995). We also
provide evidence for an in vivo interaction between
DmCdk8 and the large subunit of RNA Pol II and we
suggest that the Cdk8/cyclin C pair is structurally as
well as functionally related to the SrblO/Srbl1 pair
identified in yeast (Liao et al., 1995).
MATERIALS AND METHODS
Preparation of Extracts
Nuclear and cytoplasmic extracts were prepared from 0- to 24-h
collections of Drosophila embryos as previously described (Yoshi-
naga and Yamamoto, 1991; Sprenger et al., 1993). For cell-cycle
analysis, whole extracts from single embryos were prepared after
gentle fixing, staining with a DNA dye, and selecting the embryos
according to their position in the cell cycle (Edgar et al., 1994).
Sucrose Gradient Fractionation
Fifteen to thirty percent sucrose gradients (5 ml) in HEMK buffer
(25 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid
[HEPES]-K+, 0.1 mM EDTA, 12.5 mM MgCl2, 100 mM KCl, 1 mM
dithiothreitol, 1 mM sodium bisulfite, 1 mM benzamidine, 2 mM
phenylmethylsulfonyl fluoride, pH 7.6) were run at 26K rpm, at 4°C
for 16 h in a Beckman SW50.1 rotor. Fractions (250 ,ul) were collected
and 10 ,ul of each was analyzed by Western blotting.
Immunoblotting
Rabbit anti-cyclin C antibodies were raised against a soluble gluta-
thione S-transferase (GST)-cyclin C fusion and purified by affinity
using a different gel-purified full length cyclin C produced in Esch-
erichia coli. A monoclonal anti-cyclin C antibody (MabllCD) was
obtained after mouse injection of this gel-purified full length cyclin
C. Anti-Cdk8 antibodies were prepared as described (Tassan et al.,
1995). Mouse monoclonal anti-CTD antibody was directed against
five copies of the consensus CTD heptapeptide (a gift from M.
Vigneron and C. Kedinger, University of Louis Pasteur, Strasbourg,
Austria) (Besse et al., 1995). In our hands, it recognizes the IIa but not
the Ilo form of Drosophila RNA Pol II large subunit. Mouse mono-
clonal ARNA3 antibody (Kramer et al., 1980) was a gift from C.H.
Winter and E.K. Bautz (University of Heidelberg, Germany). Anti-
DmCdk7 antibodies will be described elsewhere (Leclerc and
Leopold, unpublished data). Western blots were developed using
chemoluminescence with horseradish peroxidase-conjugated sec-
ondary antibodies (Amersham, Arlington Heights, IL).
Polymerase Chain Reaction (PCR) Cloning
of DmCdk8
An 800-bp PCR product corresponding to the fly CDK8 sequence
(DmCDK8) was isolated using oligonucleotide primers correspond-
ing to conserved regions between the human Cdk8 protein (Tassan
et al., 1995) and the yeast Ume5 protein (Surosky et al., 1994)
(marked with arrows in Figure 3). This DNA fragment was then
used to screen an embryonic cDNA library (Brown and Kafatos,
1988) and three independent cDNA clones, similar in size, were
isolated. The sequence of the largest clone was obtained and con-
firmed by comparing with the two other clones in the coding region.
Sequence comparison and alignments were made using the Bisance
service at the CITI2 server, Paris, France (Dessen et al., 1990) and the
Clustal program, respectively.
In Vitro Expression and Interactions of Cdks
and Cyclins
DmCdk8 and DmCdc2 messenger RNAs were produced using SP6
and T3 RNA polymerases, respectively, and translated in a reticu-
locyte lysate system (Promega, Madison, WI) in the presence of
[35Slmethionine. GST, GST-cyclin C, and GST-cyclin B were pro-
duced using pGEX-2T (Pharmacia, Piscataway, NJ) and purified
from E. coli as described (Smith and Johnson, 1988). For protein
interactions, 0.5 to 2 .1A of labeled proteins were incubated with 3 ,.g
of GST, GST-cyclin C, or GST-cyclin B in the presence of 10 ,ul of
GSH-agarose beads, for 3 h at 4°C in NP buffer (HEMK, 1% NP-40).
After washing in NP buffer, the beads were resuspended in sample
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buffer, boiled, and the samples were subjected to SDS-PAGE and
revealed by fluorography. A
Immunoprecipitations
Immunoprecipitations were performed on nuclear extracts, using
either nonimmune serum or anti-Cdk8 serum (rabbit). Typically,
100 ,ul of nuclear extracts (15 mg/ml) were preincubated with gentle
rocking for 1 h at 4'C with 50 ,ul of protein A-Sepharose pellet,
completed to 1 ml with NP buffer. The supernatant was then used
for both control and anti-Cdk8 immunoprecipitations, by adding to
25 ,ul of protein A-Sepharose pellet and 1 ,j1 of either nonimmune or
immune serum and incubating another 2 h at 4°C. After four washes
with NP buffer, beads were resuspended in sample buffer, boiled,
and supernatants were loaded on 5 or 10% SDS-polyacrylamide
gels. For kinase assays, immunoprecipitates were washed again
three times with HEMK buffer, resuspended in 10 ,ul of HEMK
containing 20 mM [-y32PIATP (10 ,uCi), with or without 5 jig of a
CTD heptapeptide repeat (kindly provided by M. Dor6e, CRBM,
Montpellier, France). After a 30-min incubation at room tempera-
ture, reactions were stopped after adding 10 ,ul of 2x sample buffer
and boiling for 3 min.
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RESULTS
Characterization of a Nuclear Complex Associated
with Cyclin C
Antibodies directed against a bacterially expressed
fusion of Drosophila cyclin C and GST were affinity
purified and used in Western blots on embryonic ex-
tracts. Cyclin C migrated as a single band at 28 kDa on
SDS-PAGE, which was greatly enriched in nuclear
extracts (Figure 1A). To determine whether levels of
the protein oscillate during the cell cycle, we took
advantage of the fact that early embryonic cycles are
synchronous nuclear divisions in a syncytial cyto-
plasm. To stage embryos at precise cell-cycle intervals
they were fixed in methanol, stained for DNA, and
selected visually according to their position in the cell
cycle. Staged embryos were solubilized in SDS and
cyclin C detected by Western blots. We detected con-
stant levels of cyclin C protein during the different
phases of cell cycle 12 (Figure 1B), while a similar
analysis showed clear oscillation in cyclin A and cyclin
B levels during this cycle (Edgar et al., 1994).
To determine a possible association between cyclin
C and other nuclear proteins, embryonic nuclear ex-
tracts were run on 15-30% sucrose gradients and col-
lected fractions were probed with anti-cyclin C anti-
bodies. Cyclin C was present in a high molecular mass
complex of -500 kDa, peaking at fractions n° 9-10 in
the gradient (Figure 2). We also used other specific
antibodies to examine the distribution of various
known cell cycle proteins along the gradient. None of
the tested proteins (Dmcyclin A, Dmcyclin B, DmCdc2,
DmCdc2c, PCNA, RPA30, RPA70, and DNA-polymer-
ase a) were found to be associated with the cyclin C
fractions (our unpublished data). By contrast, antibod-
ies directed against a recently identified human kinase
named Cdk8 (Schultz and Nigg, 1993; Tassan et al.,
B
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Figure 1. Biochemical characterization of cyclin C protein. (A)
Characterization of anti-cyclin C antibodies. Thirty nanograms of
purified GST (lane 1), purified GST-cyclin C fusion (lane 2), 3 ,ul of
in vitro-translated cyclin C (lane 3), and an identical amount (5 ,tg)
of nuclear extracts (lane 4) and cytoplasmic extracts (lane 5) from
Drosophila embryos were subjected to Western blotting using affin-
ity-purified polyclonal antibodies against cyclin C. Cyclin C is pri-
marily present in the nuclear fraction, as a single 28-kDa band that
co-migrates with the in vitro translation product. (B) Cell-cycle
analysis of cyclin C protein levels. Cell-cycle 12 embryos were
selected according to their position in the cell cycle (Edgar et al.,
1994). Their protein content was then analyzed by Western blotting
using anti-cyclin C antibodies. EI, early interphase; I, interphase; P,
prophase; M, metaphase; and A/T, anaphase-telophase.
1995) cross-reacted with a 51-kDa Drosophila protein
that co-sedimented with cyclin C (Figure 2).
Isolation of a DmCDK8 Clone
Because the above results suggested that the Drosoph-
ila homologue of Cdk8 might be associated with cyclin
C, we isolated a 1.6-kb cDNA clone of the Drosophila
homologue using degenerated primers derived from
the human Cdk8 and the yeast Ume5 sequences. This
clone encodes a 454-aminoacid protein with a pre-
dicted molecular mass of 53 kDa, which we named
DmCdk8. DmCdk8 shares 72% identity with the hu-
man Cdk8 homologue (Tassan et al., 1995), 43% with
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Figure 2. Co-fractionation of cyclin C and
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 a 51-kDa protein antigenically related toCdk8 along sucrose gradient. Fractions 1( cycc *.-. (top) to 20 (bottom) were analyzed by West-em blotting using anti-cyclin C and anti-
Cdk8 antibodies (Tassan et al., 1995). Ar-
Cdk8 -. rows correspond to peaking fractions of
molecular weight standards run on a similar
gradient with corresponding molecular
I I I I1 weight. 67, bovine serum albumin; 158, al-
6 7 1 58 232 669 dolase; 232, catalase; and 669, thyroglobulin.
the yeast Ume5/SrblO protein kinase (Surosky et al.,
1994; Liao et al., 1995), and 32% with the Drosophila
Cdc2 kinase (Lehner and O'Farrell, 1990) (Figure 3).
The homology with SrblO is particularly interesting
considering that SrblO is itself the kinase partner of
Srbll, a yeast cyclin whose closest homologue (28%
identity and 58% similarity) is cyclin C (Liao et al.,
1995).
In vitro transcription and translation of DmCDK8
cDNA yielded a protein that was recognized by anti-
bodies directed against the human Cdk8 protein and
that comigrated in SDS-PAGE with the 51-kDa band
detected in Western blots of Drosophila embryonic nu-
clear extracts (Figure 4A). This indicated that the 51-
kDa protein detected along the sucrose gradients us-
ing anti-human Cdk8 antibodies corresponds indeed
to the Drosophila Cdk8 homologue. The recombinant
DmCdk8 protein was also shown to bind specifically
to a GST-cyclin C fusion in vitro (Figure 4B), indicat-
ing that Cdk8/cyclin C forms a kinase/cyclin couple
in vitro.
DmCdk8
HuCdk8
SrblO
DmCdc2
DmCdk8 Interacts In Vivo with Cyclin C and the
Large Subunit of RNA Pol II
Immunoprecipitation of nuclear extracts with anti-
Cdk8 antibodies co-precipitated DmCdk8 and cyclin
C, suggesting that they are associated in vivo (Figure
5A). We were unable to perform the reciprocal exper-
iment because our anti-cyclin C antibodies did not
immunoprecipitate endogenous cyclin C even though
they did precipitate in vitro-translated or bacterially
expressed soluble cyclin C. Because the endogenous
protein was detected by these same antibodies in
Western analysis, we attribute the failure to precipi-
tate to epitope masking by other associated proteins in
native conditions.
If cyclin C and Cdk8 are productively associated we
might expect to see kinase activity in the Cdk8 immu-
noprecipitates. Indeed, addition of ATP led to phos-
phorylation of a 240-kDa band present in the immune
complex (Figure 5C, lane 2). The size of this phospho-
protein as well as the structural homology between the
K T VEK f~~i -~IV--PG B [--
VTZ 4YE~ -IJ x(lTY trI----------
MYQRPMQVQGQQQAQSFVGKKNTIGSVHGKAPMLMANNDVFTIGPYR RKDI m1S1E fVIYIAAIGT ~1K.QINSGTNSANGSSLNGTNAK
MED F1KIEKIG EITVVGRNR---
DuCdk8-ETG |,. I' SMSACPREIA lRBN
SrblO IPQFDSTQPKSSSSMDMQANTNALRRNLLKDEGVTPGRIRTTREDVSPHYNSQKQTLIKKPLTVFYAIKKFKTEKDGV LHYI I S&CR A K5
DmCdc2 -L GQIVAMK--IRLESDDE- VPS-VS L
DmCdk8 jQVMVITL I IVKLSIIDR-FLI[DLf .IiT HI¶A|KKQV V I#SLLYQIILDGIHYHL S|NWV-LRDLK'A L YMGDG N|ERVKI.A|HuCdk8 PIN I v2Q EPLRGMYASDRLYQILDGIHYLoNWV DLKPANILVM P|EGQ VKIS
SrblO HNKHL TVEIF CH---EI;CMMVY LYAEHD F --SMP R--MI M M LD VSYLH CNWVIFH-R-P-;?AN I C--- - G
DmCdc2 ---- IYI F F KKYMDS D ----- HMES ITS ILFC_ -DKS- --LI
DnlCdk8 DrMGF;ARLFNAPLKPL9RElADLDPVVVTFWYRAPELLLGARHYT4TI DDIWA;IGC I FAELLT.;SE-P -FHCRQ SD-I NIYXHDQL QRIFNVMGFP dDK DWED
HuCdk8 DMGFARLF SPLKPILkDbtLDPVVVTFWYRAPELL,LGARHYKAI.DWAIGCIFAEDKLTSEPIFHCRQ- DtKTSNPYHDQS.DRIFNVKGFSAlRKDW i
SrblO DL :N Q F FHNYT VVWYRAPELLLGAPS GCIFA ILPKGEHF S QG p PYL
DmCdc2 LISL IR E R F RCPDI SIGCIFAIMAfRK QGDS--I D FIM1RILK¶4 TEDI'PGV
DmCdk8 [KM:PE4HTL_TTDF TS TWCSLAKYM IIIKPSPDSXKAFH1QKLt P_IKRRTT-SQAMQQYR[ -T QFDVAGIEPYYPKREF L TDDDQ EF3Sp
HuCdk8 SKMPE)AST KD TNRS|I'SD KY N V1KPDSKA FLLLjXL TXDP IKR ME OA.PY FLTDIP-S 1VYAPRREP LTEEPDEP
SrblO AYP RDDIILDPR D -NLIgTMYHSAGGRKYFiLSDSYVSi DRIMHNDNDIMNLG
DmCdc2 TS LIEDYKNTFPCMSTNQ- - -----G-Q-LTNQLKNLSANDIQjMIYIpAVNISAHEPNGFQSGLVRNKKRLQF
DmCdk8 NRR|QQQQQQQQQQQQQQQQQfQQQQQQfQQQMNI@EPN[NKRVR GNQQDFHHQQQQQQQQQQQQQQQfQfqQfMMFNQQQNF[qRFN
HuCdk8 4INIQQQiGNNHTNGTGHPGNIgDSSHTjgGPPLKKVRVVPPTT GLIMTSDYQRSNPHAAYPNPGPSTSMPjdSSMGYSATS1gQPQYSHQTHRY
SrblO SRTKNNTLQASGITAGAAANALGGLGVNRRILAA[3AAA[IAAVSGNNSDEPSRKKNRR
Figure 3. Sequence of DmCdk8 protein and alignment with HuCdk8 (Tassan et al., 1995), Ume5/SrblO (Surosky et al., 1994; Liao et al., 1995),
and DmCdc2 (Lehner and O'Farrell, 1990) sequences. Boxed residues correspond to identities between DmCdk8 and the other sequences. The
nucleotide sequence for DmCDK8 can be found in the EMBL/GenBank databases under accession number U33015.
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Figure 4. In vitro interactions between cyclin C and Cdk8. (A) In
vitro-translated DmCdk8 (retic.) is recognized by anti-Cdk8 anti-
bodies in Western blot and co-migrates in SDS-PAGE with DmCdk8
present in nuclear extracts (N.E.). (B) Cyclin C and Cdk8 interact in
vitro. [35Slmethionine-radiolabeled Cdk8 or Cdc2 proteins were
produced in vitro and incubated with either GST, GST-cyclin C, or
GST-cyclin B proteins bound to GSH-agarose beads. Retained la-
beled proteins were subjected to SDS-PAGE and detected by auto-
radiography.
Cdk8/cyclin C and the SrblO/Srbll couple suggested
that this substrate might be the large subunit of RNA Pol
II. The large subunit of RNA Pol II in Drosophila is
present in two major forms: a nonphosphorylated form,
Pol Iha, which migrates with an apparent molecular mass
of 215 kDa in PAGE, and a form with multiple phos-
phates on the CTD, Pol hIo, which migrates at -240 kDa
(Lee and Greenleaf, 1989).
To test whether RNA polymerase associates with
DmCdk8 we probed Western blots of the anti-
Cdk8 immunoprecipitations with antibodies di-
rected against the CTD of the large subunit of RNA
Pol II (anti-CTD, see Figure 5B). Although the large
subunit of RNA Pol II was specifically co-precipitated
in our conditions, only a small portion (-10%) of the
total RNA Pol II was found to interact with DmCdk8
in vivo. This observation is consistent with the original
description of the yeast holoenzyme (Koleske and
Young, 1994) where only 6% of the total RNA Pol II in
yeast cells was found to be associated in a holoenzyme
form with the SRB proteins. In our case, it suggests
either that RNA Pol II is in excess or that it participates
with different complexes in the cell, or that the asso-
ciation between DmCdk8 and RNA Pol II is weak and
partly disrupted by our experimental procedure.
We then probed the sucrose gradients fractions with
the same anti-CTD antibodies. The vast majority of Pol
II peaked at fraction n° 6 (-230 kDa), probably corre-
sponding to a monomeric form of the large subunit.
Although the resolution of the gradients did not allow
a detailed analysis of the polymerase peaks, it is clear
that a small portion of the polymerase co-fractionated
with Cdk8 up to fraction n° 12 (Figure 6). This con-
firmed the results of our anti-Cdk8 immunoprecipita-
tions and supported further an association of a portion
of Pol II with Cdk8 and cyclin C in our extracts.
To pursue the identification of the 240-kDa phos-
phoprotein labeled after ATP addition to the immune
complex, we used another monoclonal antibody di-
rected against an internal motif of RNA Pol II
(ARNA3; Kramer et al., 1980), which allowed us to
detect form hIa as well as form Ilo of RNA Pol II from
whole embryo extracts. The low sensitivity of ARNA3
antibody did not allow us to detect Ilo forms directly
in the kinase assay, but we found precise coincidence
of the phosphorylated band and the Pol IIo band
detected by antibody probing of a parallel lane on the
same gel (Figure 5C, lanes 2 and 4). As a further test,
we depleted the nuclear extracts of RNA polymerase
using anti-CTD antibodies, precipitated the Cdk8
from these depleted extracts, and examined the phos-
phorylation of proteins in the Cdk8 precipitate. Anti-
CTD antibodies were able to deplete the vast majority
of the RNA Pol II large subunit without precipitating
the Cdk8 and cyclin C proteins (Figure 5C, lanes 5 and
6). We suggest (see DISCUSSION) that Cdk8 and cy-
clin C do not precipitate with the polymerase because
the anti-CTD antibodies displace these proteins from a
complex with the polymerase. Precipitation of Cdk8
and cyclin C and addition of [y32P]ATP did not lead to
labeling of the 240-kDa band when the extract had
been depleted of polymerase (Figure 5C, lane 3). Loss
of this band upon displacement of Pol II from the
immune complex can be most simply explained if
Pol II, which in its IIo form migrates to this position,
is the substrate of the kinase. Further supporting
this conclusion, Cdk8 immunoprecipitates effi-
ciently phosphorylate a synthetic CTD heptapeptide
repeat in vitro (Figure 5D). None of the other exog-
enous kinase substrates we tried (histone Hi, f3-ca-
sein, phosvitin, HMG-I, myelin basic protein, or
GST-Rb) were phosphorylated in these conditions
(our unpublished data).
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Figure 5. Cdk8 interacts in vivo with cyclin C and RNA Pol II large subunit. (A and B) Co-immunoprecipitation of Cdk8, cyclin C and RNA
Pol II from nuclear extracts. Immunoprecipitations were performed on nuclear extracts using either a nonimmune antibody (-) or an
anti-Cdk8 antibody (+). Immunoprecipitates as well as supernatants (sup) were analyzed by Westem blotting using the following: A,
anti-Cdk8 antibodies (polyclonal, rabbit) (lanes 1-3) or anti-cyclin C antibodies (monoclonal, mouse) (lanes 4-6); and B, anti-CTD antibodies,
directed against the conserved c-terminal heptapeptide repeat of the large subunit of RNA Pol II (monoclonal, mouse). (C) A kinase activity
is associated with anti-Cdk8 immunoprecipitates. Immunoprecipitations were carried out as in panels A and B and the immunoprecipitate
was tested for autophosphorylation using [y32PIATP (lane 1, nonimmune; and lane 2, anti-Cdk8). For lane 3, the nuclear extract was first
depleted twice with anti-CTD antibodies before anti-Cdk8 immunoprecipitation. After in vitro phosphorylation, the immunoprecipitates
were separated by SDS-PAGE and revealed by autoradiography. Lane 4, whole embryo extracts were run on the same gel and analyzed by
Western blot using anti-Pol II antibodies (ARNA3) that recognize both Pol IIa and Pol Ilo forms. Lanes 5 and 6, after mock (lane 5) or anti-CTD
(lane 6) depletion, the extracts were analyzed by Westem blotting for their RNA Pol II, Cdk8, and cyclin C content. (D) Cdk8 immunocom-
plexes have a CTD kinase activity. Immunoprecipitations were carried out as in panels A, B, or C and the immunoprecipitate was tested for
kinase activity using [-y32P]ATP and a synthetic peptide (CTD3) corresponding to three copies of the consensus CTD repeat (lane 1,
nonimmune; and lane 2, anti-Cdk8).
Our present results do not show whether the kinase
activity present in anti-Cdk8 immunoprecipitates is
due to the Cdk8/cyclin C pair or to another kinase
present in the multiprotein complex with Cdk8 and
cyclin C. Recent work from several laboratories has
implicated the Cdk7/cyclin H kinase in the in vitro
phosphorylation of the CTD. We used affinity-purified
anti-DmCdk7 antibodies to test whether Cdk7 might
be present in Cdk8 immunoprecipitates. Analysis of
nuclear extracts revealed a single band that co-mi-
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Figure 6. Fractionation of Cdk8 and RNA Pol II from nuclear
extracts on sucrose gradient. Fractions 1 (top) to 20 (bottom) were
analyzed by Western blotting using anti-Cdk8 (Tassan et al., 1995)
and anti-CTD antibodies. Only the 15 first fractions are shown.
Arrows indicate the position of molecular weight standards (see
legend of Figure 2).
grated with in vitro-translated DmCdk7 protein (Fig-
ure 7, lanes 1, 4, and 5), but these same antibodies
failed to detect DmCdk7 in anti-Cdk8 immunoprecipi-
tates (Figure 7, lanes 2 and 3). Thus, although other
kinases may be present in our Cdk8 immunoprecipi-
tates, it is unlikely that Cdk7 is responsible for the
activity we detected.
DISCUSSION
Our anti-cyclin C antibodies identified cyclin C as a
nuclear protein whose level does not oscillate during
the blastoderm cell cycles in Drosophila embryos. Be-
cause analysis of the same embryos with cyclin A and
cyclin B antisera revealed mitotic destruction of these
cyclins (Edgar et al., 1994), it appears that cyclin C is
not subject to the degradation that drives oscillation of
these cyclins. Absence of mitotic destruction was fur-
ther supported by cyclin C immunolocalization in the
embryo: antigen levels were constant throughout in-
terphase nuclei, and at mitosis there was striking
localization of the antigen to mitotic chromosomes
(Leopold, unpublished observation). The protein,
which migrates in SDS-PAGE with an apparent mo-
lecular mass of 28 kDa, sediments on native sucrose
gradients with an estimated mass of -500 kDa, which
indicates that cyclin C is part of a large multiprotein
complex. This unusually large size allowed us to eas-
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Figure 7. Cdk7 is not present in anti-Cdk8 immunoprecipitates.
Control (-, lane 2) or anti-Cdk8 (+, lane 3) immunoprecipitates, as
well as supernatants (sup) were tested for the presence of DmCdk7
using affinity-purified anti-Cdk7 antibodies. DmCdk7 protein pro-
duced in a reticulocyte lysate is detected by anti-Cdk7 antibodies
and co-migrates with the band detected in nuclear extracts (lanes 1,
4, and 5).
ily test the co-sedimentation of members of the Cdk
family and other cell cycle regulators with cyclin C
fractions. Neither DmCdc2, DmCdc2c (alias DmCdk2),
cyclin A, nor cyclin B co-sedimented with cyclin C.
They were present in complexes in the 100- to 200-kDa
range as expected from previous sedimentation re-
sults (Leopold, unpublished data; Rosenblatt et al.,
1992). Consequently, the co-sedimentation of cyclin C
and a unique 51-kDa band recognized by anti-human
Cdk8 antibodies (Tassan et al., 1995) strongly sug-
gested in vivo interaction between these two mole-
cules; this was confirmed later by co-immunoprecipi-
tation of DmCdk8 and cyclin C from nuclear extracts.
It also falls in line with the recent finding that human
Cdk8 interacts specifically with cyclin C in HeLa cell
lysates (Tassan et al., 1995).
Based on sequence data for a human Cdk8 and the
yeast Ume5/SrblO protein (Surosky et al., 1994; Tassan
et al., 1995), we amplified Drosophila sequences by PCR
and isolated and sequenced a cDNA clone for the
DmCDK8 gene. The human and Drosophila Cdk8
aminoacid sequences show numerous identities, and
comparison to SrblO and other Cdks leads to a few
remarks. The classical PSTAIRE sequence that is in-
volved in Cdk-cyclin interactions (Ducommun et al.,
1991; Endicott et al., 1994; Jeffrey et al., 1995) is replaced
in both Cdk8 and SrblO by a S(M/Q)SACRE sequence,
whose conservation could reflect the presence of a
contact region for related cyclins like Srbl 1 and cyclin
C. The "T-loop" region of the Cdks is regulatory: in
the inactive structure it virtually blocks the active site,
while the active site is unmasked in the cyclin-bound
structure (Jeffrey et al., 1995). Full activation of char-
acterized Cdks requires phosphorylation of the T-loop
(for reviews see Clarke, 1995; Morgan, 1995). Al-
though the structure of the phosphorylated enzyme
has not yet been solved, based on an analogy to the
structure of the cyclic AMP-induced kinase, it has
been proposed that phosphorylation introduces new
interactions that stabilize the active conformation of
the T-loop (Jeffrey et al., 1995). Cdk8 of human and
Drosophila appear to lack a requirement for this acti-
vating phosphorylation because the T-loops of these
kinases lack candidate residues for phosphorylation
(S, T, or Y). Although SrblO has a T within its T-loop,
it is not clear whether it is analogous to the phosphor-
ylated residue in other Cdks. The ambiguity arises
because both Cdk8's and SrblO have a three-amino-
acid insertion within the T-loop, and the level of ho-
mology is not sufficient to define the correct align-
ment. Most likely the change in the T-loop occurred at
the site that is usually phosphorylated because struc-
tural comparison indicates that adjacent residues are
involved in highly conserved structure. We suggest
that the Cdk8 kinases as well as the SrblO kinase do
not require activating phosphorylation and that the
Asp residue that has been introduced roughly at the
position normally occupied by Thr provides a nega-
tive charge to substitute for phosphorylation.
Two results showed that the cloned Drosophila Cdk8
is specifically recognized by the antibody to the hu-
man Cdk8: in vitro-translated DmCdk8 protein was
recognized by anti-human Cdk8 antibodies and co-
migrated on SDS-PAGE with a 51-kDa band seen in
extracts. Western blots using this antibody showed
that DmCdk8 co-sediments with cyclin C in sucrose
gradients and immunoprecipitations showed that cy-
clin C co-precipitates with DmCdk8, suggesting that
these proteins might work in association to produce
an active kinase complex. Indeed, a kinase activity
was found in anti-Cdk8 immunoprecipitate that phos-
phorylates a 240-kDa band that co-migrates with form
IIo of RNA Pol II. We confirmed that this band corre-
sponded to form IIo of RNA Pol II by four indepen-
dent lines of evidence. 1) RNA Pol II is present in the
immunoprecipitates. 2) Depleting the extracts before
immunoprecipitation with anti-Cdk8 antibodies sup-
presses the appearance of the 240-kDa phosphorylated
band. 3) The 240-kDa phosphoprotein co-migrates ex-
actly with form IIo of RNA Pol II run on the same gel.
4) Cdk8 immunocomplexes are capable of phosphory-
lating a CTD peptide in vitro.
Attempts to precipitate the cyclin C/DmCdk8 com-
plex with two different antibodies to RNA polymerase
failed. In the case of the ARNA3 antibodies, the failure
can be simply explained because under our experi-
mental conditions we saw no precipitation of the large
subunit of RNA Pol II. Anti-CTD antibodies efficiently
immunoprecipitated Pol II in the extracts but no trace
of Cdk8 or cyclin C were detected in the immunopre-
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cipitate. Failure to co-immunoprecipitate both Cdk8
and cyclin C using anti-CTD antibodies might be due
to a variety of reasons, but we think it might reflect a
competition effect between antibody molecules and
the proteins interacting with the CTD epitopes. A
similar effect was previously suggested to explain the
separation of the RNA Pol II core enzyme and a group
of associated proteins called "the mediator" (and
among them, SrblO and Srbll) during affinity purifi-
cation experiments using anti-CTD antibodies (Kim et
al., 1994).
Our experiments do not resolve whether phosphor-
ylation of Pol II is due to the activity of the Cdk8
kinase itself. Other kinase activities might be present
in the immune complex. For this reason, we tested
for the presence of a kinase previously implicated in
phosphorylation of the CTD. Transcription factor
TFIIH, which is involved in the phosphorylation of the
CTD (Conaway and Conaway, 1989; Feaver et al., 1991;
Lu et al., 1992), contains Cdk7 and cyclin H. This pair
of proteins is responsible for the in vitro CTD-kinase
activity of the TFIIH complex (Feaver et al., 1994; Roy
et al., 1994; Serizawa et al., 1995; Shiekhattar et al.,
1995). We did not detect any trace of Drosophila Cdk7
protein in the anti-Cdk8 immune complex using affin-
ity-purified anti-DmCdk7 antibodies. This suggests ei-
ther that our experimental conditions do not allow the
stabilization of a complex comprising Cdk7 and Cdk8,
or that the two kinases associate separately with the
RNA Pol II enzyme. It indicates, furthermore, that the
kinase activity present in the anti-Cdk8 immune pre-
cipitate is not due to the Cdk7 kinase.
In conclusion, we have identified Drosophila Cdk8, a
kinase partner of cyclin C, and demonstrated that it
can interact in vivo with the large subunit of RNA Pol
II. Furthermore, DmCdk8 is associated either directly
or indirectly with a kinase activity that can phosphor-
ylate the large subunit of RNA Pol II in vitro. The
structural identity between Cdk8/cyclin C in Drosoph-
ila and SRB10/SRB11 in yeast, as well as the in vivo
interaction between RNA Pol II and Cdk8 lead us to
suggest a possible functional homology between the
two kinase/cyclin pairs. Recent results assign a role
for SRB10/SRB11 in transcriptional regulation in vivo
as well as CTD phosphorylation in vitro (Kuchin et al.,
1995; Liao et al., 1995; Wahi and Johnson, 1995). Dro-
sophila genetics as well as additional biochemical stud-
ies will help to define the precise function of Cdk8/
cyclin C. The possible involvement of cyclin C and
Cdk8 in transcription suggests that we might re-eval-
uate the basis of the original isolation of cyclin C as a
gene capable of complementing deficiencies in Gl cy-
clins in yeast. Although it is possible that cyclin C can
play a cell cycle role in a foreign context, it is also
possible that cyclin C function bypassed the Gl block
by disturbing transcriptional controls in yeast.
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